
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Svenja Müller, Claudia Zeidler, Sonja Ständer
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 1, pp. 15-33
Open Access | Times Cited: 29
Svenja Müller, Claudia Zeidler, Sonja Ständer
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 1, pp. 15-33
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Effectiveness and Safety of Dupilumab for Prurigo Nodularis in China: A Multicentric and Observational Study
Zuotao Zhao, Xiaoting Song, Yuanyuan Shang, et al.
Allergy (2025)
Open Access | Times Cited: 1
Zuotao Zhao, Xiaoting Song, Yuanyuan Shang, et al.
Allergy (2025)
Open Access | Times Cited: 1
Beyond the classic players: Mas‐related G protein‐coupled receptor member X2 role in pruritus and skin diseases
Mukesh Kumar, Ye Gi Choi, Trevor K. Wong, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 5
Mukesh Kumar, Ye Gi Choi, Trevor K. Wong, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 5
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
Lawrence F. Eichenfield, J. Z. Liu, Simran Marwaha, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 3, pp. 685-696
Open Access | Times Cited: 4
Lawrence F. Eichenfield, J. Z. Liu, Simran Marwaha, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 3, pp. 685-696
Open Access | Times Cited: 4
Update Vulvadermatologie – Diagnostik und Therapie
Christine Brägelmann, Linn Wölber, Laura Susok, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 1, pp. 65-88
Open Access
Christine Brägelmann, Linn Wölber, Laura Susok, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 1, pp. 65-88
Open Access
Worldwide prevalence of prurigo nodularis: A systematic review and meta‐analysis
Farzad Alinaghi, Mikkel Bak Jensen, Jesper Elberling, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Farzad Alinaghi, Mikkel Bak Jensen, Jesper Elberling, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses
Sabine Schmidhuber, James Dickie, Mihály Cserepes, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318293-e0318293
Open Access
Sabine Schmidhuber, James Dickie, Mihály Cserepes, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318293-e0318293
Open Access
Effective Treatment of Prurigo Nodularis With Oral Tofacitinib: A Case Report
Nikoo Mozafari
Clinical Case Reports (2025) Vol. 13, Iss. 3
Open Access
Nikoo Mozafari
Clinical Case Reports (2025) Vol. 13, Iss. 3
Open Access
Prurigo nodularis imitators unmasked
Elisabeth Victoria Goessinger, Tobias Kliesener, Beda Muehleisen, et al.
Clinics in Dermatology (2025)
Closed Access
Elisabeth Victoria Goessinger, Tobias Kliesener, Beda Muehleisen, et al.
Clinics in Dermatology (2025)
Closed Access
Type 2 Inflammation and Its Role in Dermatologic Diseases
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Taiwanese Dermatological Association consensus for the diagnosis and management of prurigo nodularis
Cheng‐Che E. Lan, Wen‐Hung Chung, Yang‐Yi Chen, et al.
Dermatologica Sinica (2025) Vol. 43, Iss. 1, pp. 2-13
Open Access
Cheng‐Che E. Lan, Wen‐Hung Chung, Yang‐Yi Chen, et al.
Dermatologica Sinica (2025) Vol. 43, Iss. 1, pp. 2-13
Open Access
American Academy of Dermatology Annual Meeting: Orlando, FL, USA, 7-11 March 2025
Kathy A Fraser
American Journal of Clinical Dermatology (2025)
Closed Access
Kathy A Fraser
American Journal of Clinical Dermatology (2025)
Closed Access
Effectiveness and Safety of Nemolizumab in Patients with Prurigo Nodularis: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ahsan Raza Raja, Zoha Zahid Fazal, Aisha Sethi
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Ahsan Raza Raja, Zoha Zahid Fazal, Aisha Sethi
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis
Sonja Ständer, Danielle Rodriguez, Carla Dias-Barbosa, et al.
Dermatology and Therapy (2025)
Open Access
Sonja Ständer, Danielle Rodriguez, Carla Dias-Barbosa, et al.
Dermatology and Therapy (2025)
Open Access
Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics
Hwa Jung Yook, Ji Hyun Lee
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5164-5164
Open Access | Times Cited: 3
Hwa Jung Yook, Ji Hyun Lee
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5164-5164
Open Access | Times Cited: 3
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: currentissues and future perspectives
Carlo Vancheri, Enrico Sciacca, Giuseppe Muscato, et al.
Multidisciplinary Respiratory Medicine (2024) Vol. 19, Iss. Vol. 19 (2024)
Open Access | Times Cited: 2
Carlo Vancheri, Enrico Sciacca, Giuseppe Muscato, et al.
Multidisciplinary Respiratory Medicine (2024) Vol. 19, Iss. Vol. 19 (2024)
Open Access | Times Cited: 2
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
Sonja Ständer, Gil Yosipovitch, Franz J. Legat, et al.
JAMA Dermatology (2024)
Closed Access | Times Cited: 2
Sonja Ständer, Gil Yosipovitch, Franz J. Legat, et al.
JAMA Dermatology (2024)
Closed Access | Times Cited: 2
Nemolizumab: a new key player in the treatment of prurigo nodularis
Adam Reich
British Journal of Dermatology (2024) Vol. 191, Iss. 2, pp. 154-155
Closed Access | Times Cited: 1
Adam Reich
British Journal of Dermatology (2024) Vol. 191, Iss. 2, pp. 154-155
Closed Access | Times Cited: 1
Prurigo nodularis: the difference between knowing the path and walking the path
J.M. Carrascosa, M. Munera‐Campos
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 480-481
Closed Access | Times Cited: 1
J.M. Carrascosa, M. Munera‐Campos
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 480-481
Closed Access | Times Cited: 1
Association between atopic dermatitis and prurigo nodularis: a systematic review and meta‐analysis
Wei Li, Yunze Pi, Jiwei Xu
International Journal of Dermatology (2024)
Closed Access | Times Cited: 1
Wei Li, Yunze Pi, Jiwei Xu
International Journal of Dermatology (2024)
Closed Access | Times Cited: 1
Update vulval dermatology – diagnostics and therapy
Christine Brägelmann, Linn Wölber, Laura Susok, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 23, Iss. 1, pp. 65-86
Open Access | Times Cited: 1
Christine Brägelmann, Linn Wölber, Laura Susok, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 23, Iss. 1, pp. 65-86
Open Access | Times Cited: 1
Baricitinib for Prurigo Nodularis: A Pilot Study on Efficacy and Safety
Padcha Pongcharoen, C Tuchinda, Panlop Chakkavittumrong, et al.
Dermatologic Therapy (2024) Vol. 2024, pp. 1-6
Open Access
Padcha Pongcharoen, C Tuchinda, Panlop Chakkavittumrong, et al.
Dermatologic Therapy (2024) Vol. 2024, pp. 1-6
Open Access
Targeted Biologic Therapies in Chronic Prurigo: The Evolving Landscape of Chronic Prurigo Treatment
Aleksandra Stefaniak, Jacek C. Szepietowski
Current Pharmaceutical Design (2024) Vol. 30, Iss. 23, pp. 1787-1790
Closed Access
Aleksandra Stefaniak, Jacek C. Szepietowski
Current Pharmaceutical Design (2024) Vol. 30, Iss. 23, pp. 1787-1790
Closed Access
Dupilumab may break the “itch‐scratch cycle” in chronic prurigo and induce remission in a subset of patients
João Teixeira, João Nuno Barbosa Soares, André Aparício‐Martins, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Closed Access
João Teixeira, João Nuno Barbosa Soares, André Aparício‐Martins, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Closed Access
TRP channels in dermatology
Attila Oláh, Attila Gábor Szöllősi, Balázs I. Tóth
Elsevier eBooks (2024), pp. 365-385
Closed Access
Attila Oláh, Attila Gábor Szöllősi, Balázs I. Tóth
Elsevier eBooks (2024), pp. 365-385
Closed Access
Time is the answer: Dupilumab effectiveness in prurigo nodularis patients
Sara Pruneddu
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 10, pp. 1848-1849
Closed Access
Sara Pruneddu
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 10, pp. 1848-1849
Closed Access